Yueying Yang

Ms. Yueying Yang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YYYueying Yang
Yueying Yang
EWE Wang
E Wang
BZBing Zhou
Bing Zhou
YLYan Lu
Yan Lu
XDXiaoying Ding
Xiaoying Ding
YLYao Li
Yao Li
RNA methylation plays a critical role in regulating all aspects of RNA function, which are implicated in the pathogenesis of various human diseases. Recent studies emphasize the role of 5-methylcytosine (m5C), an RNA modification, in key biological functions. Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the leading chronic liver condition globally. However, the relationship between m5C methylation and MASLD remains unclear. This study aimed to investigate m5C modification in a mouse model of MASLD. In this research, using RNA transcriptome sequencing (RNA-Seq) and methylated RNA bisulfite sequencing (RNA-BS-Seq) in leptin receptor-deficient mice, we found that genes associated with hypermethylation were primarily linked to lipid metabolism. We identified 156 overlapping and differentially expressed genes (DEGs) that changed at both the mRNA expression level and the m5C modification level. Among them, 72 genes showed elevated expression and m5C modification. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses indicated that these genes were significantly associated with lipid metabolism-related signaling pathways. Our results demonstrate that m5C methylation modifications may play an important role in the development of MASLD.

27 March 2026 in Biology of Reproduction
Verified
Journal Article
Closed access
PDF file
YYYueying Yang
Yueying Yang
CXChuanhao Xiong
Chuanhao Xiong
XWXiaohui Wei
Xiaohui Wei
XWXuejiao Wang
Xuejiao Wang
FKFeijuan Kong
Feijuan Kong
XDXiaoying Ding
Xiaoying Ding
Polycystic ovarian syndrome (PCOS) is a multifaceted reproductive endocrine illness marked by ovulatory dysfunction, with various causes and symptoms; it is well-accepted that hyperandrogenism and glucose metabolism disturbances significantly contribute to its progression. Our prior research demonstrated that GLP-1 receptor agonists (GLP-1RAs) could ameliorate the symptoms of PCOS mice. GLP-1RAs have the ability to control irisin expression. However, it remains ambiguous if irisin contributes to the amelioration of PCOS through GLP-1RAs. Androgen excess is a primary component influencing the phenotypic characteristics of PCOS. Evidence shows that BMP4 downregulates the CYP17A1 protein level by activating the Smad pathway, thereby inhibiting androgen synthesis. However, the relationship between irisin and BMP4 in regulating PCOS by GLP-1RAs is unclear. This study used DHEA to induce a mouse model of PCOS. After the intervention with GLP-1RAs and the integrin blocker cRGDyk (an integrin blocker that disrupts irisin signaling), the relevant indices of mice in each group were measured. We found that the ameliorating effect of GLP-1RAs on PCOS was attenuated by the combined application of the cRGDyk. Notably, after GLP-1RAs intervention, the BMP4-Smad signaling pathway was activated, and testosterone levels were significantly reduced in mice with polycystic ovary syndrome. However, this activation effect disappeared after combined use with the integrin blocker. Our study elucidates the importance of GLP-1RAs in the control of PCOS by regulating irisin and the BMP4-Smad signaling pathway. Our investigation will enhance future comprehension of PCOS from a metabolic viewpoint and investigate therapy alternatives.